ID

24611

Beschreibung

A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00509769

Link

https://clinicaltrials.gov/show/NCT00509769

Stichworte

Versionen (1)
  1. 08.08.17 08.08.17 -
Hochgeladen am

8. August 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Metastatic Breast Cancer NCT00509769

Englisch

Eligibility Metastatic Breast Cancer NCT00509769

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
signed informed consent form.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
human epidermal growth factor receptor 2 (her2)-positive metastatic breast cancer (mbc); tissue (slides or blocks) available for her2 confirmation.
Beschreibung

Secondary malignant neoplasm of female breast HER2/Neu Positive | Tissue specimen Available

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0346993
UMLS CUI [1,2]
C2348909
UMLS CUI [2,1]
C1292533
UMLS CUI [2,2]
C0470187
history of progression on her2-directed therapy for the treatment of her2-positive breast cancer.
Beschreibung

Therapeutic procedure HER2 Targeted HER2-positive carcinoma of breast

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0069515
UMLS CUI [1,3]
C1521840
UMLS CUI [1,4]
C1960398
at least 1, and no more than 3, chemotherapy regimens for mbc.
Beschreibung

Chemotherapy Regimen Quantity Secondary malignant neoplasm of female breast

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0346993
granulocyte count ≥ 1500/μl, platelet count ≥ 100,000/μl, and hemoglobin ≥ 9 g/dl.
Beschreibung

Granulocyte count | Platelet Count measurement | Hemoglobin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0857490
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0518015
serum bilirubin ≤ 1.5 mg/dl, aspartate aminotransferase (ast), alanine aminotransferase (alt), and alkaline phosphatase ≤ 2.5x the upper limit of normal (uln).
Beschreibung

Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201850
serum creatinine ≤ 1.5 mg/dl or creatinine clearance ≥ 60 ml/min.
Beschreibung

Creatinine measurement, serum | Creatinine clearance measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0373595
eastern cooperative oncology group (ecog) performance status of 0, 1, or 2.
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
any chemotherapy, hormonal therapy, radiotherapy, immunotherapy, or biological therapy for the treatment of breast cancer within 2 weeks of the first study treatment.
Beschreibung

Chemotherapy Breast Carcinoma | Hormone Therapy Breast Carcinoma | Therapeutic radiology procedure Breast Carcinoma | Immunotherapy Breast Carcinoma | Biological treatment Breast Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0678222
UMLS CUI [2,1]
C0279025
UMLS CUI [2,2]
C0678222
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C0678222
UMLS CUI [4,1]
C0021083
UMLS CUI [4,2]
C0678222
UMLS CUI [5,1]
C1531518
UMLS CUI [5,2]
C0678222
prior cumulative doxorubicin dose > 360 mg/m^2 or the equivalent.
Beschreibung

Doxorubicin Cumulative Dose

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C2986497
history of significant cardiac disease, unstable angina, congestive heart failure (chf), myocardial infarction, or ventricular arrythmia requiring medication.
Beschreibung

Heart Diseases | Angina, Unstable | Congestive heart failure | Myocardial Infarction | Ventricular arrhythmia Requirement Pharmaceutical Preparations

Datentyp

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0002965
UMLS CUI [3]
C0018802
UMLS CUI [4]
C0027051
UMLS CUI [5,1]
C0085612
UMLS CUI [5,2]
C1514873
UMLS CUI [5,3]
C0013227
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Metastatic Breast Cancer NCT00509769

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
signed informed consent form.
boolean
C0021430 (UMLS CUI [1])
Secondary malignant neoplasm of female breast HER2/Neu Positive | Tissue specimen Available
Item
human epidermal growth factor receptor 2 (her2)-positive metastatic breast cancer (mbc); tissue (slides or blocks) available for her2 confirmation.
boolean
C0346993 (UMLS CUI [1,1])
C2348909 (UMLS CUI [1,2])
C1292533 (UMLS CUI [2,1])
C0470187 (UMLS CUI [2,2])
Therapeutic procedure HER2 Targeted HER2-positive carcinoma of breast
Item
history of progression on her2-directed therapy for the treatment of her2-positive breast cancer.
boolean
C0087111 (UMLS CUI [1,1])
C0069515 (UMLS CUI [1,2])
C1521840 (UMLS CUI [1,3])
C1960398 (UMLS CUI [1,4])
Chemotherapy Regimen Quantity Secondary malignant neoplasm of female breast
Item
at least 1, and no more than 3, chemotherapy regimens for mbc.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0346993 (UMLS CUI [1,3])
Granulocyte count | Platelet Count measurement | Hemoglobin measurement
Item
granulocyte count ≥ 1500/μl, platelet count ≥ 100,000/μl, and hemoglobin ≥ 9 g/dl.
boolean
C0857490 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement
Item
serum bilirubin ≤ 1.5 mg/dl, aspartate aminotransferase (ast), alanine aminotransferase (alt), and alkaline phosphatase ≤ 2.5x the upper limit of normal (uln).
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201850 (UMLS CUI [4])
Creatinine measurement, serum | Creatinine clearance measurement
Item
serum creatinine ≤ 1.5 mg/dl or creatinine clearance ≥ 60 ml/min.
boolean
C0201976 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0, 1, or 2.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Breast Carcinoma | Hormone Therapy Breast Carcinoma | Therapeutic radiology procedure Breast Carcinoma | Immunotherapy Breast Carcinoma | Biological treatment Breast Carcinoma
Item
any chemotherapy, hormonal therapy, radiotherapy, immunotherapy, or biological therapy for the treatment of breast cancer within 2 weeks of the first study treatment.
boolean
C0392920 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
C0021083 (UMLS CUI [4,1])
C0678222 (UMLS CUI [4,2])
C1531518 (UMLS CUI [5,1])
C0678222 (UMLS CUI [5,2])
Doxorubicin Cumulative Dose
Item
prior cumulative doxorubicin dose > 360 mg/m^2 or the equivalent.
boolean
C0013089 (UMLS CUI [1,1])
C2986497 (UMLS CUI [1,2])
Heart Diseases | Angina, Unstable | Congestive heart failure | Myocardial Infarction | Ventricular arrhythmia Requirement Pharmaceutical Preparations
Item
history of significant cardiac disease, unstable angina, congestive heart failure (chf), myocardial infarction, or ventricular arrythmia requiring medication.
boolean
C0018799 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0018802 (UMLS CUI [3])
C0027051 (UMLS CUI [4])
C0085612 (UMLS CUI [5,1])
C1514873 (UMLS CUI [5,2])
C0013227 (UMLS CUI [5,3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video